Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 361601 - 361620 out of 563841 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania (VVKT) | (L01FC01) daratumumab (adm: P) | DARZALEX 1800 mg injekcinis tirpalas 15 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Dazublys 150 mg milteliai infuzinio tirpalo koncentratui N1 (CuraTeQ Biologics (Malta) Limited, Malta) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | CuraTeQBiologics[Malta]Limited,Malta |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Herzuma 150 mg milteliai infuzinio tirpalo koncentratui N1 (Celltrion Healthcare Hungary Kft., Vengrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | CelltrionHealthcareHungaryKft.,Vengrija |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Ogivri 150 mg milteliai infuzinio tirpalo koncentratui N1 (Biosimilar Collaborations Ireland Limited, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited,Airija |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Trazimera 150 mg milteliai infuzinio tirpalo koncentratui N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG,Belgija |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Zercepac 150 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Zercepac 420 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania (VVKT) | (L01FD01) trastuzumab (adm: P) | Zercepac 60 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania (VVKT) | (L01FD03) trastuzumab emtansine (adm: P) | Kadcyla 100 mg milteliai infuzinio tirpalo koncentratui N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FD03) trastuzumab emtansine (adm: P) | Kadcyla 160 mg milteliai infuzinio tirpalo koncentratui N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FD04) trastuzumab deruxtecan (adm: P) | Enhertu 100 mg milteliai infuzinio tirpalo koncentratui N1 (Daiichi Sankyo Europe GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyoEuropeGmbH,Vokietija |
| Lithuania (VVKT) | (L01FE01) cetuximab | Erbitux 5 mg/ml infuzinis tirpalas 20 ml, N1 (Merck Europe B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckEuropeB.V.,Nyderlandai |
| Lithuania (VVKT) | (L01FF01) nivolumab (adm: P) | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania (VVKT) | (L01FF01) nivolumab (adm: P) | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 24 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania (VVKT) | (L01FF01) nivolumab (adm: P) | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania (VVKT) | (L01FF01) nivolumab (adm: P) | OPDIVO 600 mg injekcinis tirpalas 5 ml N1 (Bristol-Myers Squibb/Pfizer EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibb/PfizerEEIG,Airija |
| Lithuania (VVKT) | (L01FF01) nivolumab (adm: P) | OPDIVO 600 mg injekcinis tirpalas 5 ml N1 (Bristol-Myers Squibb/Pfizer EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibb/PfizerEEIG,Airija |
| Lithuania (VVKT) | (L01FF02) pembrolizumab (adm: P) | Keytruda 25 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Merck Sharp & Dohme B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeB.V.,Nyderlandai |
| Lithuania (VVKT) | (L01FF02) pembrolizumab (adm: P) | KEYTRUDA 395 mg injekcinis tirpalas N1 (Merck Sharp & Dohme B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeB.V.,Nyderlandai |
| Lithuania (VVKT) | (L01FF02) pembrolizumab (adm: P) | KEYTRUDA 790 mg injekcinis tirpalas N1 (Merck Sharp & Dohme B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeB.V.,Nyderlandai |
Pages
